Parr Recognizes More Trials Are Needed to Validate Tocilizumab For COVID-19 Treatment
October 26, 2020
Tocilizumab, used for rheumatoid arthritis because it suppresses part of the immune response, has now been widely used for Covid-19 patients, but new studies cast doubt on the drug and the “hypothesis underlying its use.” A New York Times and Washington Post article recognized two studies in JAMA Internal Medicine...